Market Closed -
Hong Kong S.E.
09:08:22 10/05/2024 BST
|
5-day change
|
1st Jan Change
|
4.03
HKD
|
-2.42%
|
|
-1.23%
|
-37.03%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
8,811
|
3,666
|
1,569
|
1,569
|
-
|
Enterprise Value (EV)
1 |
6,660
|
1,620
|
571.6
|
-111.9
|
-49.27
|
P/E ratio
|
-159
x
|
-108
x
|
-20.1
x
|
-18.6
x
|
-124
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
58.2
x
|
21.1
x
|
9.7
x
|
4.29
x
|
2.91
x
|
EV / Revenue
|
44
x
|
9.33
x
|
2.26
x
|
-0.31
x
|
-0.09
x
|
EV / EBITDA
|
-121
x
|
-11.8
x
|
-2.9
x
|
0.74
x
|
0.69
x
|
EV / FCF
|
-108
x
|
-
|
11.6
x
|
-
|
-
|
FCF Yield
|
-0.93%
|
-
|
8.59%
|
-
|
-
|
Price to Book
|
3.92
x
|
-
|
0.72
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
425,743
|
425,743
|
421,079
|
421,079
|
-
|
Reference price
2 |
20.70
|
8.611
|
3.727
|
3.727
|
3.727
|
Announcement Date
|
25/03/22
|
27/03/23
|
27/03/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
75.28
|
151.4
|
173.5
|
253.2
|
365.9
|
539.3
|
EBITDA
1 |
-
|
-55.2
|
-137
|
-197
|
-151.8
|
-71.35
|
EBIT
1 |
-
|
-58.94
|
-140.4
|
-200.1
|
-166.6
|
-90.13
|
Operating Margin
|
-
|
-38.93%
|
-80.91%
|
-79%
|
-45.52%
|
-16.71%
|
Earnings before Tax (EBT)
1 |
-
|
-48.15
|
-35.04
|
-124.9
|
-83.1
|
-13.41
|
Net income
1 |
-
|
-48.15
|
-35.04
|
-125
|
-83.1
|
-13.41
|
Net margin
|
-
|
-31.8%
|
-20.19%
|
-49.37%
|
-22.71%
|
-2.49%
|
EPS
2 |
-
|
-0.1300
|
-0.0800
|
-0.2900
|
-0.2000
|
-0.0300
|
Free Cash Flow
1 |
-
|
-61.82
|
-
|
-32.66
|
-
|
-
|
FCF margin
|
-
|
-40.83%
|
-
|
-12.97%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/09/21
|
25/03/22
|
27/03/23
|
27/03/24
|
-
|
-
|
Fiscal Period: December |
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
59.41
|
91.99
|
71.82
|
101.7
|
110.8
|
142.4
|
156.4
|
209.4
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-28.73
|
-30.24
|
-46.7
|
-93.71
|
-65.89
|
-134.2
|
-59.74
|
-106.8
|
Operating Margin
|
-48.36%
|
-32.87%
|
-65.02%
|
-92.13%
|
-59.46%
|
-94.21%
|
-38.19%
|
-51%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-7.942
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-11.06%
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
-
|
-0.0200
|
-0.0600
|
-0.0400
|
-0.2500
|
-0.0400
|
-0.1500
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22/09/22
|
25/03/22
|
29/08/22
|
27/03/23
|
29/08/23
|
27/03/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
2,151
|
2,047
|
1,886
|
1,681
|
1,618
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-61.8
|
-
|
-32.7
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-3.24%
|
-
|
-0.9%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-3.1%
|
-
|
-0.8%
|
-
|
-
|
Assets
1 |
-
|
1,553
|
-
|
4,342
|
-
|
-
|
Book Value Per Share
2 |
-
|
5.280
|
-
|
5.150
|
-
|
-
|
Cash Flow per Share
|
-
|
-0.1200
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
17.6
|
-
|
50
|
-
|
-
|
Capex / Sales
|
-
|
11.62%
|
-
|
19.85%
|
-
|
-
|
Announcement Date
|
26/09/21
|
25/03/22
|
27/03/23
|
27/03/24
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
3.727
CNY Average target price
5.266
CNY Spread / Average Target +41.31% Consensus |
1st Jan change
|
Capi.
|
---|
| -37.03% | 217M | | +73.46% | 12.41B | | -15.61% | 8.23B | | +3.88% | 6.46B | | +14.69% | 5.5B | | -5.53% | 5.33B | | +42.58% | 5.1B | | -19.05% | 4.05B | | -32.61% | 2.54B | | +10.80% | 1.99B |
Medical Equipment
|